INGN Q3 2022 Earnings — Inogen, Inc. Revenue & Financial Results | Market Cap Arena

INGNInogen, Inc.

$171M

Q3 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$105M+13.2% YoY

Gross Profit

$43M40.6% margin

Operating Income

-$10M-9.8% margin

Net Income

-$10M-9.0% margin

EPS (Diluted)

$-0.42

QoQ Revenue Growth

+1.9%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$14M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$470M

Total Liabilities

$119M

Stockholders' Equity

$351M

Cash & Equivalents

$210M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$105M	$93M	+13.2%
Gross Profit	$43M	$48M	-10.3%
Operating Income	-$10M	$6M	-261.5%
Net Income	-$10M	$12M	-178.1%

Geographic Segments

UNITED STATES

$90M86%

Non-US

$15M14%